<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35308999</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2021</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Axes of Prognosis: Identifying Subtypes of COVID-19 Outcomes.</ArticleTitle><Pagination><StartPage>1198</StartPage><EndPage>1207</EndPage><MedlinePgn>1198-1207</MedlinePgn></Pagination><Abstract><AbstractText>COVID-19 is a disease with vast impact, yet much remains unclear about patient outcomes. Most approaches to risk prediction of COVID-19 focus on binary or tertiary severity outcomes, despite the heterogeneity of the disease. In this work, we identify heterogeneous subtypes of COVID-19 outcomes by considering 'axes' of prognosis. We propose two innovative clustering approaches - 'Layered Axes' and 'Prognosis Space' - to apply on patients' outcome data. We then show how these clusters can help predict a patient's deterioration pathway on their hospital admission, using random forest classification. We illustrate this methodology on a cohort from Wuhan in early 2020. We discover interesting subgroups of poor prognosis, particularly within respiratory patients, and predict respiratory subgroup membership with high accuracy. This work could assist clinicians in identifying appropriate treatments at patients' hospital admission. Moreover, our method could be used to explore subtypes of 'long COVID' and other diseases with heterogeneous outcomes.</AbstractText><CopyrightInformation>&#xa9;2021 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Whitfield</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Health Data Research UK, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Informatics, UCL, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coffey</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Health Data Research UK, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Huayu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiaodong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shanghai East Hospital, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Shanghai East Hospital, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Honghan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Health Data Research UK, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Informatics, UCL, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_18029</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S004149/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S004149/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>21</Day><Hour>8</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35308999</ArticleId><ArticleId IdType="pmc">PMC8861682</ArticleId><ArticleId IdType="pii">3577143</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marzano AV, Cassano N, Genovese G, Moltrasio C, Vena G. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. British Journal of Dermatology. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300648</ArticleId><ArticleId IdType="pubmed">32479680</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Liu S, Tian J, et al. Disease progression patterns and risk factors associated with mortality in deceased patients with COVID-19 in Hubei Province, China. Immunity, inflammation and disease. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461240</ArticleId><ArticleId IdType="pubmed">32857453</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. bmj. 2020. p. 369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7222643</ArticleId><ArticleId IdType="pubmed">32265220</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, Ji J, Zhao L, et al. Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps. Oncotarget. 2016;7(37):59189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5312304</ArticleId><ArticleId IdType="pubmed">27463020</ArticleId></ArticleIdList></Reference><Reference><Citation>Castaldi PJ, Boueiz A, Yun J, et al. Machine learning characterization of COPD subtypes: insights from the COPDGene study. Chest. 2020;157(5):1147&#x2013;1157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7242638</ArticleId><ArticleId IdType="pubmed">31887283</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization(WHO) Gene`ve: Switzerland: World Health Organization; 1993. The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research.</Citation></Reference><Reference><Citation>Andrade B. ICD-10 CM. 2019. Python package for handling ICD-10 codes.</Citation></Reference><Reference><Citation>Ram KS. icd10-c2d. 2020. Python package for ICD-10 codes.</Citation></Reference><Reference><Citation>Ester M, Kriegel HP, Sander J, Xu X. A Density-Based Algorithm for Discovering Clusters in Large Spatial Databases with Noise. 1996.  Available from:  www.aaai.org.</Citation></Reference><Reference><Citation>Huang Z. Extensions to the k-means algorithm for clustering large data sets with categorical values. Data Mining and Knowledge Discovery. 1998;2:283&#x2013;304. Available from:  https://link.springer.com/article/ 10.1023/A:1009769707641.</Citation></Reference><Reference><Citation>de Vos NJ. kmodes categorical clustering library. 2015&#x2013;2021.  Available from:  https://github.com/nicodv/kmodes.</Citation></Reference><Reference><Citation>Breiman L. Random forests. Machine Learning. 2001;45(1):5&#x2013;32.</Citation></Reference><Reference><Citation>Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: machine learning in Python. Journal of Machine Learning Research. 2011;12:2825&#x2013;2830.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>